| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anakinra for severe forms of COVID-19
|
Khan, Naim Akhtar
|
|
|
2 |
10 |
p. e586-e587
|
artikel
|
| 2 |
Anakinra for severe forms of COVID-19
|
Laine, Marc
|
|
|
2 |
10 |
p. e586
|
artikel
|
| 3 |
Anakinra for severe forms of COVID-19
|
Khan, Adil Rashid
|
|
|
2 |
10 |
p. e586
|
artikel
|
| 4 |
Anakinra for severe forms of COVID-19 – Authors' reply
|
Hayem, Gilles
|
|
|
2 |
10 |
p. e587-e588
|
artikel
|
| 5 |
Anti-granulocyte-macrophage colony-stimulating factor antibody otilimab in patients with hand osteoarthritis: a phase 2a randomised trial
|
Schett, Georg
|
|
|
2 |
10 |
p. e623-e632
|
artikel
|
| 6 |
B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand?
|
Mehta, Puja
|
|
|
2 |
10 |
p. e589-e590
|
artikel
|
| 7 |
Correction to Lancet Rheumatol 2020; published online Aug 21. https://doi.org/10.1016/S2665-9913(20)30304-0
|
|
|
|
2 |
10 |
p. e591
|
artikel
|
| 8 |
Correction to Lancet Rheumatol 2020; published online June 25. https://doi.org/10.1016/S2665-9913(20)30173-9
|
|
|
|
2 |
10 |
p. e591
|
artikel
|
| 9 |
COVACTA trial raises questions about tocilizumab's benefit in COVID-19
|
Furlow, Bryant
|
|
|
2 |
10 |
p. e592
|
artikel
|
| 10 |
COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study
|
Manson, Jessica J
|
|
|
2 |
10 |
p. e594-e602
|
artikel
|
| 11 |
Delving beneath the surface of hyperinflammation in COVID-19
|
Reddy, Kiran
|
|
|
2 |
10 |
p. e578-e579
|
artikel
|
| 12 |
First-in-Human study of JNJ-55920839 in healthy volunteers and patients with systemic lupus erythematosus: a randomised placebo-controlled phase 1 trial
|
Jordan, Jarrat
|
|
|
2 |
10 |
p. e613-e622
|
artikel
|
| 13 |
Hand contractures and skin nodules in a 66-year-old woman
|
Chatterjee, Soumya
|
|
|
2 |
10 |
p. e646
|
artikel
|
| 14 |
High-stakes heterogeneity in COVID-19
|
The Lancet Rheumatology,
|
|
|
2 |
10 |
p. e577
|
artikel
|
| 15 |
Iloprost for COVID-19-related vasculopathy
|
Moezinia, Carine J
|
|
|
2 |
10 |
p. e582-e583
|
artikel
|
| 16 |
Mortality in congenital heart block
|
Sonesson, Sven-Erik
|
|
|
2 |
10 |
p. e588-e589
|
artikel
|
| 17 |
Mortality in congenital heart block – Authors' reply
|
Costedoat-Chalumeau, Nathalie
|
|
|
2 |
10 |
p. e589
|
artikel
|
| 18 |
Of mice and men: converging on a common molecular understanding of osteoarthritis
|
Vincent, Tonia L
|
|
|
2 |
10 |
p. e633-e645
|
artikel
|
| 19 |
Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population
|
Hooijberg, Femke
|
|
|
2 |
10 |
p. e583-e585
|
artikel
|
| 20 |
Research in Brief
|
Thorley, Jennifer
|
|
|
2 |
10 |
p. e593
|
artikel
|
| 21 |
Targeting interferon I in SLE: a promising new perspective
|
Ríos-Garcés, Roberto
|
|
|
2 |
10 |
p. e581-e582
|
artikel
|
| 22 |
The conundrum of interleukin-6 blockade in COVID-19
|
Campochiaro, Corrado
|
|
|
2 |
10 |
p. e579-e580
|
artikel
|
| 23 |
Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study
|
Biran, Noa
|
|
|
2 |
10 |
p. e603-e612
|
artikel
|
Tijdschrift beschrijving